Celanese Balance Sheet Health
Financial Health criteria checks 1/6
Celanese has a total shareholder equity of $4.4B and total debt of $12.7B, which brings its debt-to-equity ratio to 290.5%. Its total assets and total liabilities are $22.2B and $17.8B respectively. Celanese's EBIT is $900.0M making its interest coverage ratio 1.6. It has cash and short-term investments of $1.4B.
Key information
290.50%
Debt to equity ratio
US$12.72b
Debt
| Interest coverage ratio | 1.6x |
| Cash | US$1.44b |
| Equity | US$4.38b |
| Total liabilities | US$17.79b |
| Total assets | US$22.17b |
Recent financial health updates
Recent updates
Celanese Corporation (NYSE:CE) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Feb 07
Celanese: Cost Cutting And Deleveraging Have Made It A Buy (Rating Upgrade)
Feb 05Celanese Corporation's (NYSE:CE) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 28Benign Growth For Celanese Corporation (NYSE:CE) Underpins Stock's 31% Plummet
Apr 11Is There An Opportunity With Celanese Corporation's (NYSE:CE) 45% Undervaluation?
Apr 01Celanese Corporation: Fresh Funds May Mitigate Potential Material Dividend Cut
Mar 25The Market Doesn't Like What It Sees From Celanese Corporation's (NYSE:CE) Revenues Yet As Shares Tumble 29%
Feb 21Celanese Cuts Its Dividend And Investors Cut Their Losses
Feb 08Celanese Presents Attractive Risk-Adjusted Return For Patient Investors
Dec 05Celanese Corporation: The Pain Of Leverage
Nov 12Celanese: Sold In January 2024, Back In Again With A 'Buy'
Oct 21Celanese Corporation: Margin Expansion Story Doesn't Offset Leverage Risks
Aug 07Celanese: Debt Front Loaded, Performance Still On Drawing Board
May 23Celanese: Appetite For Acquisitions Remains
Mar 11Financial Position Analysis
Short Term Liabilities: CE's short term assets ($6.1B) exceed its short term liabilities ($3.7B).
Long Term Liabilities: CE's short term assets ($6.1B) do not cover its long term liabilities ($14.1B).
Debt to Equity History and Analysis
Debt Level: CE's net debt to equity ratio (257.6%) is considered high.
Reducing Debt: CE's debt to equity ratio has increased from 138.2% to 290.5% over the past 5 years.
Debt Coverage: CE's debt is not well covered by operating cash flow (10.9%).
Interest Coverage: CE's interest payments on its debt are not well covered by EBIT (1.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/08 20:57 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Celanese Corporation is covered by 34 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Ghansham Panjabi | Baird |
| Sergey Vasnetsov | Barclays |